Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 2 from your keywords: subject="Venous thromboembolis...
cover
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Comment Share
Agnelli G

The primary efficacy outcome occurred in 59 of 2609 patients (2.3%) in the apixaban group, as compared with 71 of 2635 (2.7%) in the conventional-therapy group (relative risk, 0.84; 95% confidence interval [CI], 0.60 to 1.18; difference in risk [apixaban minus conventional therapy], −0.4 percentage points; 95% CI, −1.3 to 0.4). Apixaban was noninferior to conventional therapy (P

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Efficacy and safety of fondaparinux for the prevention of venous thromboembol…
Comment Share
Cohen AT

To determine the efficacy and safety of the anticoagulant fondaparinux in older acute medical inpatients at moderate to high risk of venous thromboembolism

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-